By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Animal genetics companies MetaMorphix (MMI) and Stirius have teamed to form AquaAnimal Health, a joint venture that will use MMI's biomarker-based technology to sustain certain characteristics in aquaculture animals such as finfish and crustaceans.

Under the agreement, MMI has granted AcquAnimal Health a license to its proprietary Myostatin technology and an option to its Genius Whole Genome System for use in aquaculture applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Oct
11
Sponsored by
ArcherDX

This webinar will discuss a validation study for a next-generation sequencing (NGS) assay for hematological malignancies (e.g., acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms).